NEW YORK (GenomeWeb) – French diagnostics firm Novacyt today announced it has secured flexible bond financing for up to €5 million ($5.5 million) over three years as part of a private placement.

The financing was underwritten by YA Global Master. Novacyt said that it has drawn the first €250,000 tranche and will draw on the remaining €4.75 million at its discretion and control.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.